The top five "game changers" in vaccinology: Toward rational and directed vaccine development

OMICS A Journal of Integrative Biology

Volumn 15, Issue 9, 2011, Pages 533-537

  Kennedy, Richard B ^a,b   Poland, Gregory A ^a,b  

^a Mayo Vaccine Research Group   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ADAPTIVE IMMUNITY; BIOINFORMATICS; BIOMICS; DRUG RESEARCH; DRUG SAFETY; GENE SEQUENCE; HUMAN; IMMUNOGENOMICS; INNATE IMMUNITY; NEXT GENERATION SEQUENCING; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMS BIOLOGY; VACCINE PRODUCTION; VACCINOMICS;

COMPUTATIONAL BIOLOGY; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; SYSTEMS BIOLOGY; VACCINES;

EID: 80052776804     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2011.0012     Document Type: Review

References (42)

1. Alkhalil, A., Hammamieh, R., Hardick, J., Ichou, M.A., Jett, M., and Ibrahim, S. (2010). Gene expression profiling of monkeypox virus-infected cells reveals novel interfaces for host-virus interactions. Virol J 7, 173.
2. Berry, M.P., Graham, C.M., McNab, F.W., Xu, Z., Bloch, S.A., Oni, T., et al. (2010). An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973-977.
3. Bonnevie-Nielsen, V., Field, L.L., Lu, S., Zheng, D.J., Li, M., Martensen, P.M., et al. (2005). Variation in antiviral 20,50- oligoadenylate synthetase (2050AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene. Am J Hum Genet 76, 623-633. (Pubitemid 40432169)
4. Cheema, A.K., Timofeeva, O., Varghese, R., Dimtchev, A., Shiekh, K., Shulaev, V., et al. (2011). Integrated analysis of ATM mediated gene and protein expression impacting cellular metabolism. J Proteome Res. 10, 2651-2657.
5. Cho, J.H., Gelinas, R., Wang, K., Etheridge, A., Piper, M.G., Batte, K., et al. (2011). Systems biology of interstitial lung diseases: integration of mRNA and microRNA expression changes. BMC Med Genomics 4, 8.
6. Davies, D.H., Wyatt, L.S., Newman, F.K., Earl, P.L., Chun, S., Hernandez, J.E., et al. (2008). Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax. J Virol 82, 652-663.
7. Dhiman, N., Smith, D.I., and Poland, G.A. (2009). Next-generation sequencing: a transformative tool for vaccinology. Expert Rev Vaccines 8, 963-967.
8. Ebrahimi, S.M., and Tebianian, M. (2011). Influenza A viruses: why focusing on M2e-based universal vaccines. Virus Genes 42, 1-8.
9. Edmondson, A.C., Brown, R.J., Kathiresan, S., Cupples, L.A., Demissie, S., Manning, et al. (2009). Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans. J Clin Invest 119, 1042-1050.
10. Germain, R.N. (2001). The art of the probable: system control in the adaptive immune system. Science 293, 240-245. (Pubitemid 32694729)
11. Germain, R.N. (2010). Vaccines and the future of human immunology. Immunity 33, 441-450.
12. Gupta, S., Maurya, M.R., Merrill, A.H., Jr., Glass, C.K., and Subramaniam, S. (2011). Integration of lipidomics and transcriptomics data towards a systems biology model of sphingolipid metabolism. BMC Syst Biol 5, 26.
13. Haralambieva, I.H., and Poland, G.A. (2010). Vaccinomics, predictive vaccinology and the future of vaccine development. Future Microbiol 5, 1757-1760.
14. Horner, D.S., Pavesi, G., Castrignano, T., De Meo, P.D., Liuni, S., Sammeth, M., et al. (2010). Bioinformatics approaches for genomics and post genomics applications of next-generation sequencing. Briefings Bioinformat 11, 181-197.
15. Janikashvili, N., Larmonier, N., and Katsanis, E. (2010). Personalized dendritic cell-based tumor immunotherapy. Immunotherapy 2, 57-68.
16. Keasey, S., Pugh, C., Tikhonov, A., Chen, G., Schweitzer, B., Nalca, A., et al. (2010). Proteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination. PloS One 5, e15547.
17. Lim, J.K., Lisco, A., McDermott, D.H., Huynh, L., Ward, J.M., Johnson, B., et al. (2009). Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathogens 5, e1000321.
18. Lucas, M., Mashimo, T., Frenkiel, M.P., Simon-Chazottes, D., Montagutelli, X., Ceccaldi, P.E., et al. (2003). Infection of mouse neurones by West Nile virus is modulated by the interferon-inducible 20-50 oligoadenylate synthetase 1b protein. Immunol Cell Biol 81, 230-236. (Pubitemid 36649270)
19. Lynn, D.J., Winsor, G.L., Chan, C., Richard, N., Laird, M.R., Barsky, A., et al. (2008). InnateDB: facilitating systems-level analyses of the mammalian innate immune response. Mol Syst Biol 4, 218.
20. Maione, D., Margarit, I., Rinaudo, C.D., Masignani, V., Mora, M., Scarselli, M., et al. (2005). Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science 309, 148-150. (Pubitemid 40934997)
21. Marguerat, S.,Wilhelm, B.T., and Bahler, J. (2008). Next-generation sequencing: applications beyond genomes. Biochem Soc Trans 36, 1091-1096.
22. Martin, P., Barton, A., and Eyre, S. (2011). ASSIMILATOR: a new tool to inform selection of associated genetic variants for functional studies. Bioinformatics 27, 144-146.
23. Mashimo, T., Lucas, M., Simon-Chazottes, D., Frenkiel, M.P., Montagutelli, X., Ceccaldi, P.E., et al. (2002). A nonsense mutation in the gene encoding 20-50-oligoadenylate synthetase/ L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc Natl Acad Sci USA 99, 11311-11316. (Pubitemid 34920922)
24. McCauley, J.L., Kenealy, S.J., Margulies, E.H., Schnetz-Boutaud, N., Gregory, S.G., Hauser, S.L. (2007). SNPs in multi-species conserved sequences (MCS) as useful markers in association studies: a practical approach. BMC Genomics 8, 266.
25. McGarvey, P.B., Huang, H., Mazumder, R., Zhang, J., Chen, Y., Zhang, C., et al. (2009). Systems integration of biodefense omics data for analysis of pathogen-host interactions and identification of potential targets. PloS One 4, e7162.
26. Metzker, M.L. (2010). Sequencing technologies-the next generation. Nat Rev 11, 31-46.
27. Morozova, O., and Marra, M.A. (2008). Applications of nextgeneration sequencing technologies in functional genomics. Genomics 92, 255-264.
28. Poland, G.A. (2007). Pharmacology, vaccinomics, and the second golden age of vaccinology. Clin Pharmacol Ther 82, 623-626. (Pubitemid 350114819)
29. Poland, G.A., and Oberg, A.L. (2010). Vaccinomics and bioinformatics: accelerants for the next golden age of vaccinology. Vaccine 28, 3509-3510.
30. Poland, G.A., Ovsyannikova, I.G., Jacobson, R.M., and Smith, D.I. (2007). Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics. Clin Pharmacol Ther 82, 653-664. (Pubitemid 350114830)
31. Poland, G.A., Ovsyannikova, I.G., and Jacobson, R.M. (2008). Personalized vaccines: the emerging field of vaccinomics. Expert Opin Biol Ther 8, 1659-1667.
32. Poland, G.A., Jacobson, R.M., and Ovsyannikova, I.G. (2009). Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics. Vaccine 27, 3240-3244.
33. Pulendran, B., Li, S., and Nakaya, H.I. (2010). Systems vaccinology. Immunity 33, 516-529.
34. Querec, T.D., Akondy, R.S., Lee, E.K., Cao, W., Nakaya, H.I., and Teuwen, D. (2009). Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 10, 116-125.
35. Rubins, K.H., Hensley, L.E., Relman, D.A., and Brown, P.O. (2011). Stunned silence: gene expression programs in human cells infected with monkeypox or vaccinia virus. PloS One 6, e15615.
36. Schadt, E.E., Linderman, M.D., Sorenson, J., Lee, L., and Nolan, G.P. (2010). Computational solutions to large-scale data management and analysis. Nat Rev 11, 647-657.
37. Shapira, S.D., Gat-Viks, I., Shum, B.O., Dricot, A., De Grace, M.M., Wu, L., et al. (2009). A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139, 1255-1267.
38. Tisoncik, J.R., Belisle, S.E., Diamond, D.L., Korth, M.J., and Katze, M.G. (2009). Is systems biology the key to preventing the next pandemic? Future Virol 4, 553-561.
39. Yakub, I., Lillibridge, K.M., Moran, A., Gonzalez, O.Y., Belmont, J., Gibbs, R.A. et al. (2005). Single nucleotide polymorphisms in genes for 20-50-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection. J Infect Dis 192, 1741-1748. (Pubitemid 41587824)
40. Yan, Q. (2010). Immunoinformatics and systems biology methods for personalized medicine. Methods Mol Biology 662, 203-220.
41. Yang, Z., Bruno, D.P., Martens, C.A., Porcella, S.F., and Moss, B. (2010). Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing. Proc Natl Acad Sci USA 107, 11513-11518.
42. Zak, D.E., and Aderem, A. (2009). Systems biology of innate immunity. Immunol Rev 227, 264-282.